Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

MicroRNA profile in site-specific head and neck squamous cell cancer

D. Kalfert, M. Pesta, V. Kulda, O. Topolcan, A. Ryska, P. Celakovsky, J. Laco, M. Ludvikova,

. 2015 ; 35 (4) : 2455-63.

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16000170

BACKGROUND/AIM: MicroRNAs (miRs) are non-coding RNA molecules regulating diverse cellular processes essential in carcinogenesis. Little is known regarding miRs in head and neck squamous cell cancer (HNSCC). The aim of the present study was to investigate miRs in relation to the clinico pathological features of site-specific HNSCC. MATERIALS AND METHODS: The study comprised of 51 patients with HNSCC (23 oropharyngeal, 24 laryngeal and 4 hypopharyngeal carcinomas). Total RNA was extracted from tumor tissue and normal squamous epithelium using the miRNeasy FFPE Kit. A quantitative estimation of let-7a, miR-21, miR-200c, miR-34a, miR-375 was performed by a real-time polymerase chain reaction (PCR) method using the TagMan® MicroRNA assay. Additionally, p16 expression was detected by immuno histo chemistry. RESULTS: Significant differences of let-7a, miR-200c, miR-34a levels between oropharyngeal and laryngeal cancers were found (p<0.05). Compared to non-neoplastic tissues, miR-21, miR-200c, miR-34a were up-regulated and miR-375 was down-regulated in tumors of all sites. MiR-34a tumor levels significantly correlated with oropharyngeal origin (p=0.0284) and p16 positivity (p=0.0218). CONCLUSION: The microRNA profile seems to play a potential role in the pathobiology of oropharyngeal and laryngeal HNSCC. Up-regulation of miR34a in p16-positive oropharyngeal cancer has not been so far described and additional studies are warranted.

000      
00000naa a2200000 a 4500
001      
bmc16000170
003      
CZ-PrNML
005      
20200121084420.0
007      
ta
008      
160108s2015 gr f 000 0|eng||
009      
AR
035    __
$a (PubMed)25862914
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Kalfert, David $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
245    10
$a MicroRNA profile in site-specific head and neck squamous cell cancer / $c D. Kalfert, M. Pesta, V. Kulda, O. Topolcan, A. Ryska, P. Celakovsky, J. Laco, M. Ludvikova,
520    9_
$a BACKGROUND/AIM: MicroRNAs (miRs) are non-coding RNA molecules regulating diverse cellular processes essential in carcinogenesis. Little is known regarding miRs in head and neck squamous cell cancer (HNSCC). The aim of the present study was to investigate miRs in relation to the clinico pathological features of site-specific HNSCC. MATERIALS AND METHODS: The study comprised of 51 patients with HNSCC (23 oropharyngeal, 24 laryngeal and 4 hypopharyngeal carcinomas). Total RNA was extracted from tumor tissue and normal squamous epithelium using the miRNeasy FFPE Kit. A quantitative estimation of let-7a, miR-21, miR-200c, miR-34a, miR-375 was performed by a real-time polymerase chain reaction (PCR) method using the TagMan® MicroRNA assay. Additionally, p16 expression was detected by immuno histo chemistry. RESULTS: Significant differences of let-7a, miR-200c, miR-34a levels between oropharyngeal and laryngeal cancers were found (p<0.05). Compared to non-neoplastic tissues, miR-21, miR-200c, miR-34a were up-regulated and miR-375 was down-regulated in tumors of all sites. MiR-34a tumor levels significantly correlated with oropharyngeal origin (p=0.0284) and p16 positivity (p=0.0218). CONCLUSION: The microRNA profile seems to play a potential role in the pathobiology of oropharyngeal and laryngeal HNSCC. Up-regulation of miR34a in p16-positive oropharyngeal cancer has not been so far described and additional studies are warranted.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a nádorové biomarkery $x biosyntéza $x genetika $7 D014408
650    _2
$a spinocelulární karcinom $x genetika $x patologie $7 D002294
650    _2
$a proliferace buněk $x genetika $7 D049109
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a nádory hlavy a krku $x genetika $x patologie $7 D006258
650    _2
$a lidé $7 D006801
650    _2
$a nádory hrtanu $x genetika $x patologie $7 D007822
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x biosyntéza $x genetika $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory orofaryngu $x genetika $x patologie $7 D009959
650    _2
$a transkriptom $x genetika $7 D059467
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pesta, Martin $u Institute of Biology, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic Central Immunoanalytical Laboratory, Department of Nuclear Medicine, Faculty Hospital in Pilsen, Pilsen, Czech Republic.
700    1_
$a Kulda, Vlastimil $u Department of Biochemistry, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
700    1_
$a Topolcan, Ondrej $u Central Immunoanalytical Laboratory, Department of Nuclear Medicine, Faculty Hospital in Pilsen, Pilsen, Czech Republic.
700    1_
$a Ryska, Ales $u The Fingerland Department of Pathology, University Hospital Hradec Kralove, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Celakovsky, Petr $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Laco, Jan $u The Fingerland Department of Pathology, University Hospital Hradec Kralove, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Ludvikova, Marie $u Institute of Biology, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic ludvikova.m@email.cz marie.ludvikova@lfp.cuni.cz.
773    0_
$w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 35, č. 4 (2015), s. 2455-63
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25862914 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20200121084757 $b ABA008
999    __
$a ok $b bmc $g 1102451 $s 924376
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 35 $c 4 $d 2455-63 $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
LZP    __
$a Pubmed-20160108

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...